Published on
February 11, 2026
- 14:00 GMT
Atticus Pharma Announces Clinical Data for ATC-002, a Pharmaceutical Product Candidate for Androgenic Alopecia
GREENVILLE, SC, UNITED STATES, February 11, 2026 /EINPresswire.com/ -- • ATC-002 is a topical treatment designed to stimulate new hair growth in subjects with androgenic alopecia. • ATC-002 uses Atticus’s proprietary Z-pod® technology to create a …
Distribution channels:
Banking, Finance & Investment Industry, Beauty & Hair Care
...
